Attorney Detail Banner
Back to Attorneys
Rycroft, Krista

Krista M. Rycroft

Of Counsel

kristarycroft@quinnemanuel.com
Direct Tel: +1 212-849-7461
New York
Tel: +1 212 849 7000 Fax: +1 212 849 7100

Krista Rycroft is Of Counsel in Quinn Emanuel's New York office. She has extensive experience in all aspects of patent litigation at the trial and appellate levels for both patentees and defendants. In addition to her litigation experience, Ms. Rycroft also has extensive experience in client counseling including licensing, due diligence, and validity and freedom-to-operate opinions. Ms. Rycroft has represented clients involved in a variety of complex technologies, including pharmaceuticals, medical devices, biotechnology, telecommunications, and mechanical devices. Ms. Rycroft has litigated in numerous Federal courts throughout the country, including the District of New Jersey, District of Delaware, Northern District of California, Eastern District of Texas, and District of Massachusetts. She is admitted to practice in the State of New York, the Court of Appeals for the Federal Circuit, the Court of Appeals for the First Circuit, and various District Courts. Ms. Rycroft was Co-Chair of the Women in IP Law Committee for the New York Intellectual Property Law Association (2014-2016).

  • California Institute of Technology
  • Cisco
  • Forest Laboratories
  • Ironwood Pharmaceuticals
  • Marvell Semiconductor
  • Time Warner Cable
  • Representing Forest Laboratories and Ironwood Pharmaceuticals in Hatch-Waxman patent infringement litigation brought to protect Linzess® brand linaclotide products for the treatment of IBS-C and CIC. (D. Del.)
  • Representing Forest Laboratories, LLC in Hatch-Waxman patent infringement litigation brought to protect its Namzaric™ brand extended-release memantine hydrochloride/donepezil hydrochloride products for the treatment of Alzheimer's (D. Del.)
  • Represented Forest Laboratories, LLC in Hatch-Waxman patent infringement litigation brought to protect its Namenda XR® brand extended-release memantine hydrochloride products for the treatment of Alzheimer's. (D. Del.)
  • Represented Marvell Semiconductor in a patent suit asserting a patent purporting to cover turbo-coding. Won a partial summary judgment that eliminated 80% of sales from the damages calculation. Following a jury trial, successfully obtained a favorable damages verdict more than five times less than what plaintiff sought, and obtained a complete defense judgment after post-trial motions. (N.D. Cal.)
  • Represented Meda Pharmaceuticals Inc. in Hatch-Waxman patent infringement litigation brought to protect its Astepro® brand anti-allergy nasal spray. The case settled favorably with consent judgments including injunctions against multiple defendants. (D. N.J.)
  • Represented Pfizer in Hatch-Waxman patent infringement litigation brought to protect its Celebrex® brand anti-inflammatory drug. Following a bench trial, Pfizer obtained final judgment that the patents-in-suit were valid and infringed. (D. N.J.)
  • Represented Symbol Technologies and Cognex Corp. against the Lemelson Foundation patents asserted against bar code and machine vision equipment. Following a two-and-a-half month trial, all of the Lemelson patent claims were held invalid, unenforceable, and not infringed. (D. Nev.)
  • Represented Duracell, a Gillette subsidiary, at trial involving Rayovac's assertion of three patents relating to zinc-air hearing aid batteries. Obtained a complete defense jury verdict. (W.D. Wis.)
  • The George Washington University Law School
    (J.D., 1999)
  • John Hopkins University
    (M.S.E., Environmental Engineering, 1996)
  • University of Massachusetts
    (B.S., Chemical Engineering, 1994)
The State Bar of New York; United States Court of Appeals: Federal Circuit, First Circuit; United State District Courts: Southern District of New York, Eastern District of New York, Eastern District of Wisconsin, District of Colorado
  • Kaye Scholer LLP:
    • Associate, 2005-2009
  • Fish & Neave LLP (Ropes & Gray LLP):
    • Associate, 1999-2005
  • “Patent Damages 2016: Year in Review,” American Intellectual Property Law Association Webinar Panelist, February 16, 2017.
  • “The Markman Process,” CLE Presentation:  Practicing Law Institute, April 19, 2016.
  • “The Markman Process,” CLE Presentation:  Practicing Law Institute, April 17, 2015.
  • “The Markman Process,” CLE Presentation:  Practicing Law Institute, April 21, 2014.
  • “The Markman Process,” Fundamentals of Patent Litigation (PLI 2014).
  • Pharmaceutical and Biotech Patent Law, Chapter 5:5, Enablement (PLI 2008).
  • "Phillips v. AWH Corp.: Bringing Consistency to Claim Interpretation," CLE Presentation: Wyeth, September 20, 2005.
  • "Federal Circuit Sets Forth Claim Construction Guidelines In An Effort To Bring Predictability To Claim Interpretation," Kaye Scholer Patent Law Newsletter, July 2005.
  • "Is Grain Processing 'Important'?," Law Seminars International, Calculating & Proving Patent Damages, May 14, 2004.
  • "Is Uniformity In Patent Law Still Achievable?," The New York Law Journal, May 12, 2003.
  • "The Effects Of Statements In Foreign Prosecution On U.S. Patents In Litigation," New York Intellectual Property Law Association Joint Patent Seminar, New York, May 2, 2002.
  • "Jury's Role Shrinks In Patent Litigation," The National Law Journal, January 21, 2002.